Zongqiang Hu

696 total citations · 1 hit paper
16 papers, 514 citations indexed

About

Zongqiang Hu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zongqiang Hu has authored 16 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zongqiang Hu's work include MicroRNA in disease regulation (6 papers), Ferroptosis and cancer prognosis (6 papers) and RNA modifications and cancer (4 papers). Zongqiang Hu is often cited by papers focused on MicroRNA in disease regulation (6 papers), Ferroptosis and cancer prognosis (6 papers) and RNA modifications and cancer (4 papers). Zongqiang Hu collaborates with scholars based in China and United States. Zongqiang Hu's co-authors include Jianghua Ran, Yingpeng Zhao, Yanfeng Yin, Shengning Zhang, Jie Jiang, Hongqiang Gao, Chuntao Yan, Yi‐Ting Wang, Li Li and Li Wang and has published in prestigious journals such as Life Sciences, Molecular Cancer and International Immunopharmacology.

In The Last Decade

Zongqiang Hu

15 papers receiving 509 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma

2023 202 citations Zongqiang Hu, Yingpeng Zhao et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zongqiang Hu China	11	377	298	106	89	67	16	514
Jianghua Ran China	10	338 0.9×	276 0.9×	58 0.5×	50 0.6×	76 1.1×	30	482
Kequan Xu China	12	387 1.0×	287 1.0×	99 0.9×	46 0.5×	43 0.6×	19	517
Gao‐Min Liu China	9	267 0.7×	232 0.8×	163 1.5×	36 0.4×	78 1.2×	16	461
Kwan Man Hong Kong	5	543 1.4×	199 0.7×	51 0.5×	44 0.5×	72 1.1×	5	688
Xianxiong Ma China	12	259 0.7×	133 0.4×	65 0.6×	77 0.9×	41 0.6×	26	394
Huamei Wei China	13	466 1.2×	394 1.3×	63 0.6×	83 0.9×	56 0.8×	29	587
Mincheng Yu China	14	232 0.6×	160 0.5×	89 0.8×	111 1.2×	53 0.8×	32	453
Qinliang Fang China	10	356 0.9×	252 0.8×	77 0.7×	23 0.3×	54 0.8×	15	442
Rong Yan China	10	195 0.5×	181 0.6×	57 0.5×	53 0.6×	93 1.4×	39	428
Qiangnu Zhang China	12	277 0.7×	217 0.7×	65 0.6×	29 0.3×	35 0.5×	24	372

Countries citing papers authored by Zongqiang Hu

Since Specialization

Citations

This map shows the geographic impact of Zongqiang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongqiang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongqiang Hu more than expected).

Fields of papers citing papers by Zongqiang Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongqiang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongqiang Hu. The network helps show where Zongqiang Hu may publish in the future.

Co-authorship network of co-authors of Zongqiang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Zongqiang Hu. A scholar is included among the top collaborators of Zongqiang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongqiang Hu. Zongqiang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Jiang, Jie, et al.. (2025). ATF5 inhibits autophagy and the Wnt/β-catenin pathway by upregulating mTOR to suppress the stemness of liver cancer stem cells. Tissue and Cell. 97. 103094–103094.

Hu, Zongqiang, et al.. (2023). miR-21-5p Inhibits Ferroptosis in Hepatocellular Carcinoma Cells by Regulating the AKT/mTOR Signaling Pathway through MELK. Journal of Immunology Research. 2023. 1–20. 31 indexed citations

Hu, Zongqiang, Yingpeng Zhao, Jie Jiang, et al.. (2023). Exosome‐derived miR ‐142‐5p from liver stem cells improves the progression of liver fibrosis by regulating macrophage polarization through CTSB. Environmental Toxicology. 38(8). 1860–1873. 9 indexed citations

Li, Wang, Shengning Zhang, Yingpeng Zhao, et al.. (2023). Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma. Clinical & Translational Oncology. 25(7). 2099–2115. 2 indexed citations

Hu, Zongqiang, Chuntao Yan, Zhiqiang Li, et al.. (2023). Autophagy affects hepatic fibrosis progression by regulating macrophage polarization and exosome secretion. Environmental Toxicology. 38(7). 1665–1677. 11 indexed citations

Hu, Zongqiang, et al.. (2023). MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24. Life Sciences. 325. 121773–121773. 19 indexed citations

Hu, Zongqiang, et al.. (2023). Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma. International Immunopharmacology. 126. 111149–111149. 21 indexed citations

Hu, Zongqiang, Yingpeng Zhao, Jie Jiang, et al.. (2023). Metformin promotes ferroptosis and sensitivity to sorafenib in hepatocellular carcinoma cells via ATF4/STAT3. Molecular Biology Reports. 50(8). 6399–6413. 22 indexed citations

Hu, Zongqiang, Hongyu Zhang, Yi‐Ting Wang, et al.. (2023). Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease. Lipids in Health and Disease. 22(1). 33–33. 15 indexed citations

10.

Hu, Zongqiang, Yingpeng Zhao, Hongqiang Gao, et al.. (2023). Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Molecular Cancer. 22(1). 55–55. 202 indexed citations breakdown →

11.

Hu, Zongqiang, Hui Zhang, Wei Liu, et al.. (2022). Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression. Translational Cancer Research. 11(5). 1173–1187. 27 indexed citations

12.

Hu, Zongqiang, Yanfeng Yin, Jie Jiang, et al.. (2022). Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression. Journal of Gastrointestinal Oncology. 13(2). 754–767. 49 indexed citations

13.

Hu, Zongqiang, et al.. (2022). Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3. Journal of Immunology Research. 2022. 1–14. 33 indexed citations

14.

Hu, Zongqiang, Li Li, Jianghua Ran, et al.. (2019). miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro. Annals of Hepatology. 18(6). 825–832. 10 indexed citations

15.

Hu, Zongqiang, et al.. (2017). IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma. Cellular Physiology and Biochemistry. 43(6). 2379–2390. 55 indexed citations

16.

Chen, Gang, Hong Liu, Zongqiang Hu, et al.. (2015). A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients. European Journal of Gastroenterology & Hepatology. 27(8). 901–906. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact